Squarepoint Ops LLC raised its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 32.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 211,900 shares of the financial services provider's stock after acquiring an additional 52,031 shares during the quarter. Squarepoint Ops LLC owned approximately 0.50% of Trupanion worth $10,214,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently modified their holdings of the business. Vanguard Group Inc. grew its stake in shares of Trupanion by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock valued at $173,362,000 after acquiring an additional 45,653 shares during the period. Marshall Wace LLP lifted its holdings in Trupanion by 6.9% during the fourth quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider's stock valued at $43,459,000 after purchasing an additional 57,804 shares in the last quarter. Balyasny Asset Management L.P. boosted its position in shares of Trupanion by 368.2% in the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock worth $40,548,000 after purchasing an additional 661,559 shares during the period. Baillie Gifford & Co. increased its stake in shares of Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock worth $33,806,000 after purchasing an additional 147,341 shares in the last quarter. Finally, Northern Trust Corp raised its position in shares of Trupanion by 9.0% during the 4th quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock valued at $17,749,000 after purchasing an additional 30,549 shares during the period.
Trupanion Stock Up 0.1%
Shares of TRUP stock opened at $44.18 on Friday. The company's fifty day simple moving average is $38.78 and its two-hundred day simple moving average is $44.10. Trupanion, Inc. has a 52 week low of $25.90 and a 52 week high of $57.90. The stock has a market cap of $1.89 billion, a P/E ratio of -192.09, a PEG ratio of 6.02 and a beta of 1.72. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39.
Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.02. The business had revenue of $341.98 million during the quarter, compared to analysts' expectations of $337.81 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm's revenue for the quarter was up 11.7% compared to the same quarter last year. During the same quarter last year, the business posted ($0.16) EPS. Analysts predict that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Insider Activity at Trupanion
In other Trupanion news, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $45.86, for a total transaction of $183,440.00. Following the completion of the transaction, the chief executive officer now owns 118,784 shares in the company, valued at $5,447,434.24. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Emily Dreyer sold 14,025 shares of Trupanion stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.41, for a total transaction of $454,550.25. Following the completion of the transaction, the senior vice president now directly owns 27,645 shares of the company's stock, valued at $895,974.45. The trade was a 33.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 37,792 shares of company stock valued at $1,306,242. 5.42% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Several brokerages recently weighed in on TRUP. Stifel Nicolaus dropped their target price on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a report on Thursday, February 20th. Piper Sandler dropped their price objective on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research note on Thursday, February 20th. Finally, Lake Street Capital decreased their target price on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $51.80.
Read Our Latest Stock Analysis on Trupanion
Trupanion Company Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.